Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

High-risk blastemal Wilms tumor can be modeled by 3D spheroid cultures in vitro.

Wegert J, Zauter L, Appenzeller S, Otto C, Bausenwein S, Vokuhl C, Ernestus K, Furtwängler R, Graf N, Gessler M.

Oncogene. 2019 Sep 27. doi: 10.1038/s41388-019-1027-8. [Epub ahead of print]

PMID:
31562394
2.

TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia.

Wegert J, Vokuhl C, Ziegler B, Ernestus K, Leuschner I, Furtwängler R, Graf N, Gessler M.

J Pathol Clin Res. 2017 Aug 14;3(4):234-248. doi: 10.1002/cjp2.77. eCollection 2017 Oct.

3.

Kaposiformes Hämangioendotheliom mit Kasabach-Merritt-Syndrom: erfolgreiche Therapie mit Sirolimus.

Reichel A, Hamm H, Wiegering V, Wiewrodt B, Neubauer H, Ernestus K, Winkler B.

J Dtsch Dermatol Ges. 2017 Mar;15(3):329-331. doi: 10.1111/ddg.12987_g. No abstract available.

PMID:
28252859
4.

Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: successful treatment with sirolimus.

Reichel A, Hamm H, Wiegering V, Wiewrodt B, Neubauer H, Ernestus K, Winkler B.

J Dtsch Dermatol Ges. 2017 Mar;15(3):329-331. doi: 10.1111/ddg.12987. Epub 2017 Feb 21. No abstract available.

PMID:
28220608
5.

Mandibular intraosseous pseudocarcinomatous hyperplasia: a case report.

Fuchs A, Hartmann S, Ernestus K, Mutzbauer G, Linz C, Brands RC, Kübler AC, Müller-Richter UD.

J Med Case Rep. 2016 Sep 29;10(1):268.

6.

Dermatom und Diffusion--Diagnostik und Therapiekontrolle eines undifferenzierten embryonalen Sarkoms der Leber.

Neubauer H, Wölfl M, Ernestus K.

Rofo. 2016 Apr;188(4):389-91. doi: 10.1055/s-0041-107202. Epub 2015 Nov 3. German. No abstract available.

PMID:
26529268
7.

Pediatric dermatohistopathology--histopathology of skin diseases in newborns and infants.

Wobser M, Ernestus K, Hamm H.

J Dtsch Dermatol Ges. 2015 Jun;13(6):535-48. doi: 10.1111/ddg.12651. Review. English, German.

PMID:
26018366
8.

Co-Occurence of Reciprocal Translocation and COL2A1 Mutation in a Fetus with Severe Skeletal Dysplasia: Implications for Genetic Counseling.

Heinrich T, Nanda I, Rehn M, Zollner U, Ernestus K, Wirth C, Schlüter G, Schmid M, Kunstmann E.

Cytogenet Genome Res. 2015;145(1):25-8. doi: 10.1159/000381169. Epub 2015 Mar 25.

PMID:
25823796
9.

[Pediatric carcinoma of the adrenal cortex - a rare and interdisciplinary diagnosis].

Kunz AS, Wirth C, Ernestus K, Veldhoen S.

Rofo. 2015 Apr;187(4):293-6. doi: 10.1055/s-0034-1385206. Epub 2014 Sep 22. German. No abstract available.

PMID:
25243530
10.

[Muscular sarcocystosis after travel to Malaysia: a case series from Germany].

Slesak G, Tappe D, Keller C, Cramer J, Güthoff W, Zanger P, Frank M, Ernestus K, Rauthe S, Stich A, Schäfer J.

Dtsch Med Wochenschr. 2014 May;139(19):990-5. doi: 10.1055/s-0034-1370004. Epub 2014 Apr 29. German.

PMID:
24782151
11.

Hit the mark with diffusion-weighted imaging: metastases of rhabdomyosarcoma to the extraocular eye muscles.

Hassold N, Warmuth-Metz M, Winkler B, Kreissl MC, Ernestus K, Beer M, Neubauer H.

BMC Pediatr. 2014 Feb 27;14:57. doi: 10.1186/1471-2431-14-57.

12.

Initial patient cluster and first positive biopsy findings in an outbreak of acute muscular Sarcocystis-like infection in travelers returning from Tioman island, Peninsular Malaysia, in 2011.

Tappe D, Ernestus K, Rauthe S, Schoen C, Frosch M, Müller A, Stich A.

J Clin Microbiol. 2013 Feb;51(2):725-6. doi: 10.1128/JCM.03063-12. Epub 2012 Dec 5. No abstract available.

13.

[Inflammatory myofibroblastic tumor of the greater omentum in a 1.5-year-old boy].

Backhaus K, Grasshoff-Derr S, Ernestus K, Meyer T.

Chirurg. 2012 Sep;83(9):815-8. doi: 10.1007/s00104-012-2332-8. German. No abstract available.

PMID:
22790589
14.

Benchmarking of mutation diagnostics in clinical lung cancer specimens.

Querings S, Altmüller J, Ansén S, Zander T, Seidel D, Gabler F, Peifer M, Markert E, Stemshorn K, Timmermann B, Saal B, Klose S, Ernestus K, Scheffler M, Engel-Riedel W, Stoelben E, Brambilla E, Wolf J, Nürnberg P, Thomas RK.

PLoS One. 2011 May 5;6(5):e19601. doi: 10.1371/journal.pone.0019601.

15.

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

Weiss J, Sos ML, Seidel D, Peifer M, Zander T, Heuckmann JM, Ullrich RT, Menon R, Maier S, Soltermann A, Moch H, Wagener P, Fischer F, Heynck S, Koker M, Schöttle J, Leenders F, Gabler F, Dabow I, Querings S, Heukamp LC, Balke-Want H, Ansén S, Rauh D, Baessmann I, Altmüller J, Wainer Z, Conron M, Wright G, Russell P, Solomon B, Brambilla E, Brambilla C, Lorimier P, Sollberg S, Brustugun OT, Engel-Riedel W, Ludwig C, Petersen I, Sänger J, Clement J, Groen H, Timens W, Sietsma H, Thunnissen E, Smit E, Heideman D, Cappuzzo F, Ligorio C, Damiani S, Hallek M, Beroukhim R, Pao W, Klebl B, Baumann M, Buettner R, Ernestus K, Stoelben E, Wolf J, Nürnberg P, Perner S, Thomas RK.

Sci Transl Med. 2010 Dec 15;2(62):62ra93. doi: 10.1126/scitranslmed.3001451. Erratum in: Sci Transl Med. 2011 Jan 19;3(66):66er2. Sci Transl Med. 2012 Apr 18;4(130):130er2.

16.

Osteoblastic response in patients with non-small cell lung cancer with activating EGFR Mutations and bone metastases during treatment with EGFR kinase inhibitors.

Ansén S, Bangard C, Querings S, Gabler F, Scheffler M, Seidel D, Saal B, Zander T, Nogová L, Töpelt K, Markert E, Stoelben E, Ernestus K, Thomas RK, Wolf J.

J Thorac Oncol. 2010 Mar;5(3):407-9. doi: 10.1097/JTO.0b013e3181cf32aa. No abstract available. Erratum in: J Thorac Oncol. 2010 Jun;5(6):926.

17.

[Invasive pulmonary aspergillosis. Occurrence in a non-neutropenic female patient with abdominal sepsis].

Knüttgen D, Kamp M, Ströhlein M, Matten J, Chemaissani A, Ernestus K, Sakka SG, Wappler F.

Anaesthesist. 2009 Mar;58(3):262-7. doi: 10.1007/s00101-008-1496-6. German.

PMID:
19247622
18.
19.

Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97.

Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, Scheel-Walter HG, Schwabe D, Schilling FH, Benz-Bohm G, Berthold F.

J Clin Oncol. 2008 Mar 20;26(9):1504-10. doi: 10.1200/JCO.2007.12.3349.

PMID:
18349403
20.

True thymic hyperplasia associated with severe thymic cyst bleeding in a newborn: case report and review of the literature.

Eifinger F, Ernestus K, Benz-Bohm G, Körber F, Hünseler C, Hekmat K, Marx A, Roth B.

Ann Diagn Pathol. 2007 Oct;11(5):358-62. Epub 2007 Jul 24. Review.

PMID:
17870024
21.

Detection of primary choriocarcinoma in the mediastinum by F-18 FDG positron emission tomography.

Bachmann J, Ernestus K, Werner T, Garnier Y, Mallmann P, Pietsch C, Schicha H, Schmidt M.

Clin Nucl Med. 2007 Aug;32(8):663-5.

PMID:
17667449
22.

High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status.

Westermann F, Henrich KO, Wei JS, Lutz W, Fischer M, König R, Wiedemeyer R, Ehemann V, Brors B, Ernestus K, Leuschner I, Benner A, Khan J, Schwab M.

Clin Cancer Res. 2007 Aug 15;13(16):4695-703. Epub 2007 Jul 25.

23.

Frequency and diagnostic patterns of lymphomas in liver biopsies with respect to the WHO classification.

Loddenkemper C, Longerich T, Hummel M, Ernestus K, Anagnostopoulos I, Dienes HP, Schirmacher P, Stein H.

Virchows Arch. 2007 May;450(5):493-502. Epub 2007 Mar 13.

24.

A mycobacterial gene involved in synthesis of an outer cell envelope lipid is a key factor in prevention of phagosome maturation.

Robinson N, Wolke M, Ernestus K, Plum G.

Infect Immun. 2007 Feb;75(2):581-91. Epub 2006 Nov 6.

25.

Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.

Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R, Ernestus K, König R, Haas S, Eils R, Schwab M, Brors B, Westermann F, Fischer M.

J Clin Oncol. 2006 Nov 1;24(31):5070-8.

PMID:
17075126
26.

Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome.

Spitz R, Oberthuer A, Zapatka M, Brors B, Hero B, Ernestus K, Oestreich J, Fischer M, Simon T, Berthold F.

Genes Chromosomes Cancer. 2006 Dec;45(12):1130-42.

PMID:
16958102
27.

Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome.

Fischer M, Oberthuer A, Brors B, Kahlert Y, Skowron M, Voth H, Warnat P, Ernestus K, Hero B, Berthold F.

Clin Cancer Res. 2006 Sep 1;12(17):5118-28.

28.

[Structure, use, and risks of biomaterial repositories of embryonal tumors].

Ernestus K, Pietsch T, Gessler M, Simon T, Hero B, Berthold F.

Klin Padiatr. 2006 May-Jun;218(3):132-8. German.

PMID:
16688668
29.

Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.

Spitz R, Betts DR, Simon T, Boensch M, Oestreich J, Niggli FK, Ernestus K, Berthold F, Hero B.

Cancer Genet Cytogenet. 2006 May;167(1):51-6.

PMID:
16682287
30.

AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping.

Hoffmann C, Tiemann M, Schrader C, Janssen D, Wolf E, Vierbuchen M, Parwaresch R, Ernestus K, Plettenberg A, Stoehr A, Fatkenheuer G, Wyen C, Oette M, Horst HA.

Blood. 2005 Sep 1;106(5):1762-9. Epub 2005 May 19.

PMID:
15905193
31.

Lacking immunocytological GD2 expression in neuroblastoma: report of 3 cases.

Schumacher-Kuckelkorn R, Hero B, Ernestus K, Berthold F.

Pediatr Blood Cancer. 2005 Aug;45(2):195-201.

PMID:
15800908
32.

A case of chronic calcium pyrophosphate dihydrate crystal disease (tophaceous pseudogout) in the temporomandibular joint.

Meul B, Ernestus K, Neugebauer J, Kuebler AC.

Oral Dis. 2005 Mar;11(2):113-5.

PMID:
15752086
33.

MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification.

Spitz R, Hero B, Skowron M, Ernestus K, Berthold F.

Eur J Cancer. 2004 Dec;40(18):2753-9.

PMID:
15571958
34.

Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma.

Wölfl M, Jungbluth AA, Garrido F, Cabrera T, Meyen-Southard S, Spitz R, Ernestus K, Berthold F.

Cancer Immunol Immunother. 2005 Apr;54(4):400-6. Epub 2004 Sep 24.

PMID:
15449039
35.

The bi-specific CD3 x NCAM antibody: a model to preactivate T cells prior to tumour cell lysis.

Jensen M, Ernestus K, Kemshead J, Klehr M, Von Bergwelt-Baildon MS, Schinköthe T, Schultze JL, Berthold F.

Clin Exp Immunol. 2003 Nov;134(2):253-63.

36.

Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.

Spitz R, Hero B, Ernestus K, Berthold F.

Clin Cancer Res. 2003 Oct 15;9(13):4835-40.

37.

FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.

Spitz R, Hero B, Ernestus K, Berthold F.

Med Pediatr Oncol. 2003 Jul;41(1):30-5.

PMID:
12764740
38.

Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.

Spitz R, Hero B, Ernestus K, Berthold F.

Clin Cancer Res. 2003 Jan;9(1):52-8.

39.

Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.

Spitz R, Hero B, Westermann F, Ernestus K, Schwab M, Berthold F.

Genes Chromosomes Cancer. 2002 Jul;34(3):299-305.

PMID:
12007190

Supplemental Content

Loading ...
Support Center